US FDA approves Mirum's Ctexli tablets to treat cerebrotendinous xanthomatosis
Mirum Pharmaceuticals, Inc. announced that the US Food and Drug Administration (FDA) has approved Ctexli (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous xanthomatosis (CTX). Ctexli is the first and only treatment …